Literature DB >> 21188518

Long-term cultures of stem/progenitor cells from lobular and ductal breast carcinomas under non-adherent conditions.

Agostina Nardone1, Sara Corvigno, Annalisa Brescia, Daniel D'Andrea, Gennaro Limite, Bianca Maria Veneziani.   

Abstract

A small subpopulation of stem/progenitor cells can give rise to the diversity of differentiated cells that comprise the bulk of the tumor. Are proliferating cells, within the bulk of tumor, few cells with uncommon features? The cell biological approach provides a limitless model for studying the hierarchical organization of progenitor subpopulation and identifying potential therapeutic targets. Aim of the study was to expand patients' breast cancer cells for evaluating functional cell properties, and to characterize the protein expression profile of selected cells to be compared with that of primary tumors. Breast cancer cells from estrogen receptor (ERα) positive, HER2 negative lobular (LoBS cells) and ductal (DuBS cells) histotype were cultured under non-adherent conditions to form mammospheres. Sorting of the cells by their surface expression of CD24 and CD44 gave rise to subpopulations which were propagated, enriched and characterized for the expression of epithelial and stromal markers. We found that non-adherent culture conditions generate mammospheres of slowly proliferating cells; single cells, dissociated from mammospheres, grow in soft agar; long-term cultured LoBS and DuBS cells, CD44+/CD24low, express cytokeratin 5 (CK5), α-smooth muscle actin (α-sma) and vimentin, known as markers of basal/myoepithelial cells; and ERα (only DuBS cells), HER1 (EGF-Receptor), activated HER2, and cyclinD1 as markers of luminal epithelial cell. Isolates of cells from breast cancer patients may be a tool for a marker-driven testing of targeted therapies.

Entities:  

Year:  2010        PMID: 21188518      PMCID: PMC3021146          DOI: 10.1007/s10616-010-9328-3

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  54 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

2.  HER2 status and benefit from adjuvant trastuzumab in breast cancer.

Authors:  Soonmyung Paik; Chungyeul Kim; Norman Wolmark
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  The development of epithelial phenotypes in the human fetal and infant breast.

Authors:  R Anbazhagan; P P Osin; J Bartkova; B Nathan; E B Lane; B A Gusterson
Journal:  J Pathol       Date:  1998-02       Impact factor: 7.996

5.  Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells.

Authors:  James C Garbe; Sanchita Bhattacharya; Batul Merchant; Ekaterina Bassett; Karen Swisshelm; Heidi S Feiler; Andrew J Wyrobek; Martha R Stampfer
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

6.  A banking strategy toward customized therapy in breast cancer.

Authors:  Agostina Nardone; Carla Cavaliere; Sara Corvigno; Gennaro Limite; Sabino De Placido; Bianca Maria Veneziani
Journal:  Cell Tissue Bank       Date:  2009-01-29       Impact factor: 1.522

7.  Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.

Authors:  Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Giovanni Mazzarol; Manuela Vecchi; Simona Ronzoni; Loris Bernard; Giuseppe Viale; Pier Giuseppe Pelicci; Pier Paolo Di Fiore
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

Review 8.  Intratumoral estrogen production in breast carcinoma: significance of aromatase.

Authors:  Takashi Suzuki; Yasuhiro Miki; Noriaki Ohuchi; Hironobu Sasano
Journal:  Breast Cancer       Date:  2008-07-12       Impact factor: 4.239

9.  Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours.

Authors:  J Bartek; J Taylor-Papadimitriou; N Miller; R Millis
Journal:  Int J Cancer       Date:  1985-09-15       Impact factor: 7.396

10.  HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer.

Authors:  Christian F Singer; Daphne Gschwantler-Kaulich; Anneliese Fink-Retter; Georg Pfeiler; Ingrid Walter; Gernot Hudelist; Samir Helmy; Anne-Catherine Spiess; Wolfgang Lamm; Ernst Kubista
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-26       Impact factor: 4.553

View more
  4 in total

1.  Dysregulated expression of Dicer in invasive ductal breast carcinoma.

Authors:  Ali Akbar Poursadegh Zonouzi; Azim Nejatizadeh; Mohammad Rahmati-Yamchi; Hedieh Fardmanesh; Samira Shakerizadeh; Ahmad Poursadegh Zonouzi; Kazem Nejati-Koshki; Mohammad Shekari
Journal:  Med Oncol       Date:  2015-06-16       Impact factor: 3.064

Review 2.  MicroRNAs in endometrial cancer.

Authors:  Kouji Banno; Megumi Yanokura; Iori Kisu; Wataru Yamagami; Nobuyuki Susumu; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2013-02-05       Impact factor: 3.402

3.  [Enrichment and function research of large cell lung cancer stem cell-like cells].

Authors:  Wenke Yue; Feng Jiao; Bin Liu; Jiacong You; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-06

4.  Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells.

Authors:  C D'Amato; R Rosa; R Marciano; V D'Amato; L Formisano; L Nappi; L Raimondo; C Di Mauro; A Servetto; F Fulciniti; A Cipolletta; C Bianco; F Ciardiello; B M Veneziani; S De Placido; R Bianco
Journal:  Br J Cancer       Date:  2014-08-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.